COI.
close Submit Innovation
close
Biotechnology verified Verified Outcome TRL 9

Enterprise Generative AI (Commercial)

domain Client: A leading mRNA biotechnology company handshake Provider: OpenAI / ChatGPT Enterprise schedule Deploy: 2023
85 Impact
Enterprise Ready
Evidence Score: A/10
Strength: High

Executive Summary

ANALYST: COI RESEARCH

Enterprise-wide rollout of a custom instance of ChatGPT ('mChat') to accelerate legal, commercial, and operational workflows.

rate_review Analyst Verdict

"Medium Risk (Data Security). Establishing a private instance is the correct mitigation. High adoption rate indicates genuine utility beyond the hype."

lock
Full Audit Report Available Includes Risk Register, Technical Specs & Compliance Data.

warning The Challenge

Employees were using public GenAI tools, creating IP leakage risks. The company needed a secure, internal way to leverage LLMs for drafting contracts, summarizing scientific literature, and creating marketing copy.

psychology The Solution

Deployed ChatGPT Enterprise (mChat) to thousands of employees. Built specific GPTs for different departments (e.g., 'Dose ID' for clinical dose selection).

settings_suggest Technical & Deployment Specs

Integrations
SSO
Deployment Model
SaaS (Private Tenant)
Data Classification
Internal / Commercial
Estimated TCO / ROI
Moderate
POC Summary ( to )

"N/A"

shield Risk Register & Mitigation

Risk Factor Severity Mitigation Strategy
Hallucination Medium User training 'Human in loop'

trending_up Impact Trajectory

Audited value realization curve

Adoption by >50% of workforce in first months Verified Outcome
Primary KPICreated >750 custom GPTs
Audit CycleZero IP leakage incidents reported (due to private instance)

policy Compliance & Gov

  • Standards: Internal / IP Protection
  • Maturity (TRL): 9
  • Evidence Score: A/10
  • Data Class: Internal / Commercial

folder_shared Verified Assets

description
Verified Case Study
PDF • Version 1
lock
verified_user
Technical Audit
PDF • Audited
lock
Security Architecture

The "Blind Verification" Protocol

How we verified these outcomes for A leading mRNA biotechnology company without exposing sensitive IP or identities.

Private
lock_person

1. Raw Evidence

Audit ID: #PRIV-542
Evidence: Direct SQL Logs
Public
public

2. Verified Asset

Outcome: Verified
Ref ID: #COI-542

Strategic Action Center

Identify your current stage and take the next step.

rocket_launch
Replicate This Success
Want similar results? Request a deployment consultation.
psychology_alt
Submit Challenge
Have a different problem? Submit your problem statement.
publish
Publish Case Study
Submit your own verified evidence.
thumb_up
Verify Impact
Audit your existing solution.